Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
NCT ID: NCT05484700
Last Updated: 2022-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
305 participants
OBSERVATIONAL
2021-12-30
2022-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
NCT04520880
Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
NCT05131594
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
NCT04543006
Monitoring the IgG/IgM Antibodies in COVID-19 Patients
NCT04810117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full recovery group; patients with asymptomatic symptoms
* post COVID-19 they had not received any additional COVID vaccine
Exclusion Criteria
* pregnant patients,
* people who had a history of allergic reactions after COVID-19 vaccination or any drugs
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Korapat Mayurasakorn, MD.
Role: PRINCIPAL_INVESTIGATOR
Doctor in Family Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1013/2564(IRB3)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.